Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs QID✓SelectedUSD · QIDGSK vs QID performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs QID

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.1%
QID return
-70.1%
Excess return
+111.3%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioQIDExcessAlpha
1D-0.1%+11.0%-11.1%+0.6%
7D-5.3%+22.9%-28.3%-4.1%
30D-3.7%+37.2%-40.8%-1.6%
3M-7.3%+32.3%-39.5%-5.5%
6M-4.2%+30.1%-34.4%-2.4%
YTD+0.9%-3.8%+4.7%+0.5%
1Y+7.3%-12.4%+19.6%+6.2%
3Y+52.7%-62.2%+114.9%+42.1%
All+41.1%-70.1%+111.3%+30.6%

Cumulative growth

Daily Returns

Daily percentage return beside QID.

Daily Out/Under-Performance

Portfolio return minus QID return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × QID return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded QID wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling